mV25™ was formulated using the CytoSolve® computational systems biology platform – a technology for Precision and Personalized Medicine – invented by Dr.SHIVA at MIT. This formulation results from computing billions of potential combinations to discover an optimal synergy of compounds that downregulate the biomarkers of pain and inflammation molecular pathways integrated from thousands of peer-reviewed scientific papers across 4 decades in 68 research institutions.
CytoSolve® OPTIMIZEDTM means this formula has been optimized to maximize efficacy and bioavailability while minimizing toxicity based on current research curated by CytoSolve®. As the science advances, so will this formulation. This is our promise.